TrialObesity surgery2013
A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels.
Nina Sauer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it